Experimental Rodent Models of Vascular Dementia: A Systematic Review / Nidhi Tiwari, Jyoti Upadhyay, Mohammad Nazam Ansari, Syed Shadab Raza, Wasim Ahmad, Mohammad Azam Ansari
Vascular Dementia (VaD) occurs due to cerebrovascular insufficiency, which leads to decreased blood circulation to the brain, thereby resulting in mental disabilities. The main causes of Vascular Cognitive Impairment (VCI) are severe hypoperfusion, stroke, hypertension, large vessel disease (cortical), small Vessel Disease (subcortical VaD), strategic infarct, hemorrhage (microbleed), Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL), and Cerebral Amyloid Angiopathy (CAA), which leads to decreased cerebrovascular perfusion. Many metabolic disorders such as Diabetes Mellitus (DM), dyslipidemia, and hyperhomocysteinemia are also related to VaD. The rodent experimental models provide a better prospective for the investigation of the molecular mechanism of new drugs. A plethora of experimental models are available that mimic the pathological conditions and lead to VaD. This review article updates the current knowledge on the basis of VaD, risk factors, pathophysiology, mechanism, advantages, limitations, and the modification of various available rodent experimental models.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:20 |
|---|---|
| Enthalten in: |
CNS & neurological disorders, drug targets - 20(2021), 7, Seite 657- |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Tiwari, Nidhi [VerfasserIn] |
|---|
| Links: |
FID Access [lizenzpflichtig] |
|---|
| Umfang: |
1 Online-Ressource (16 p) |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
KFL008973083 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | KFL008973083 | ||
| 003 | DE-627 | ||
| 005 | 20231128082000.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220316s2021 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)KFL008973083 | ||
| 035 | |a (KFL)prod_DARH_.41C3A7388B68B25D741C1644AB346FC94BBB0989 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 084 | |a PHARM |q DE-84 |2 fid | ||
| 100 | 1 | |a Tiwari, Nidhi |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Experimental Rodent Models of Vascular Dementia: A Systematic Review |c Nidhi Tiwari, Jyoti Upadhyay, Mohammad Nazam Ansari, Syed Shadab Raza, Wasim Ahmad, Mohammad Azam Ansari |
| 264 | 1 | |c 2021 | |
| 300 | |a 1 Online-Ressource (16 p) | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Vascular Dementia (VaD) occurs due to cerebrovascular insufficiency, which leads to decreased blood circulation to the brain, thereby resulting in mental disabilities. The main causes of Vascular Cognitive Impairment (VCI) are severe hypoperfusion, stroke, hypertension, large vessel disease (cortical), small Vessel Disease (subcortical VaD), strategic infarct, hemorrhage (microbleed), Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL), and Cerebral Amyloid Angiopathy (CAA), which leads to decreased cerebrovascular perfusion. Many metabolic disorders such as Diabetes Mellitus (DM), dyslipidemia, and hyperhomocysteinemia are also related to VaD. The rodent experimental models provide a better prospective for the investigation of the molecular mechanism of new drugs. A plethora of experimental models are available that mimic the pathological conditions and lead to VaD. This review article updates the current knowledge on the basis of VaD, risk factors, pathophysiology, mechanism, advantages, limitations, and the modification of various available rodent experimental models | ||
| 700 | 1 | |a Upadhyay, Jyoti |e verfasserin |4 aut | |
| 700 | 1 | |a Ansari, Mohammad Nazam |e verfasserin |4 aut | |
| 700 | 1 | |a Raza, Syed Shadab |e verfasserin |4 aut | |
| 700 | 1 | |a Ahmad, Wasim |e verfasserin |4 aut | |
| 700 | 1 | |a Ansari, Mohammad Azam |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t CNS & neurological disorders, drug targets |d Saif Zone, Sharjah, U.A.E. : [Verlag nicht ermittelbar], 2006 |g 20(2021), 7, Seite 657- |h Online-Ressource |w (DE-627)KFL000006513 |w (DE-600)2254204-8 |w (DE-576)273891022 |x 1996-3181 |7 nnns |
| 773 | 1 | 8 | |g volume:20 |g year:2021 |g number:7 |g pages:657- |
| 856 | 4 | 0 | |u http://pharmazie.proxy.fid-lizenzen.de/fid/bentham-ejournals-pharmazie/www.eurekaselect.com/openurl/content.php?genre=article&issn=1871-5273&volume=20&issue=7&spage=657 |m X:KFL |x Verlag |y FID Access |z lizenzpflichtig |
| 912 | |a ZDB-1-BEJ | ||
| 912 | |a GBV_KFL | ||
| 912 | |a FID-PHARM | ||
| 912 | |a SSG-OLC-PHA | ||
| 935 | |i IMPORT_0628_prod_DARH_02 | ||
| 951 | |a AR | ||
| 952 | |d 20 |j 2021 |e 7 |h 657- | ||